Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy (MADIT-CRT) Post Approval Registry



Status:Completed
Conditions:Cardiology
Therapuetic Areas:Cardiology / Vascular Diseases
Healthy:No
Age Range:21 - Any
Updated:5/27/2013
Start Date:March 2011
End Date:December 2013
Contact:Arthur J Moss, MD
Email:heartajm@heart.rochester.edu
Phone:585-275-5391

Use our guide to learn which trials are right for you!

Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy Post Approval Registry


MADIT-CRT PAR is an FDA mandated follow-up registry for patients that participated in the
MADIT-CRT IDE study examining long-term mortality.


The registry is designed to determine the long-term mortality benefit as a result of Cardiac
Resynchronization Therapy with Defibrillation (CRT-D) vs. Implantable Cardioverter
Defibrillator (ICD) therapy in the MADIT-CRT study patient population. The registry will
collect data on patients that previously participated at MADIT-CRT sites within the US
through five years of participation from their orginal enrollment in the MADIT-CRT IDE
study.

Inclusion Criteria:

- Active patients who were enrolled in the MADIT-CRT IDE within the United States

Exclusion Criteria:

- Patients who are unable or unwilling to comply with the protocol requirements
We found this trial at
1
site
Rochester, New York 14642
?
mi
from
Rochester, NY
Click here to add this to my saved trials